This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Understand the reasons for choosing a retirement plan over a 401k. Make informed decisions for a secure retirement.
23,531 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Lowe's 2026 earnings outlook hinges on margin discipline and online growth. This guide breaks down what to watch and ...
BitMine is tapping an established finance model to raise money for Ethereum buys. This article breaks down how a 9.5%...
President Trump pivots his inflation push toward gasoline retailers, aiming for pump relief as inflation remains abov...
Premium cinema formats are drawing crowds and lifting ticket revenues, signaling a shift in consumer budgets and thea...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
When a high profile government move hits a new domain in the headlines, markets pay attention. This piece breaks down...
Curious if you can own SpaceX stock before its IPO through Hyperliquid? This guide explains why that pre-IPO thrill o...
BWET has surged on a geopolitically driven spike in tanker rates. The rally hinges on one event, and a calm could tri...
A routine cash withdrawal becomes a clue in a larger investigation. Learn how a $560 ATM event helped uncover extensi...
Four buyers claim they paid an ex-NBA player for paintings, commissions, and jerseys that never arrived. This caution...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.